A role of mast cell glycosaminoglycans for the immunological expulsion of intestinal nematode, Strongyloides venezuelensis.
We examined effects of mast cell glycosaminoglycans on the establishment of the intestinal nematode, Strongyloides venezuelensis, in the mouse small intestine. When intestinal mastocytosis occurred, surgically implanted adult worms could not invade and establish in the intestinal mucosa. In mast cell-deficient W/Wv mice, inhibition of adult worm invasion was not evident as compared with littermate +/+ control mice. Mucosal mastocytosis and inhibition of S. venezuelensis adult worm mucosal invasion was tightly correlated. To determine effector molecules for the invasion inhibition, adult worms were implanted with various sulfated carbohydrates including mast cell glycosaminoglycans. Among sulfated carbohydrates tested, chondroitin sulfate (ChS)-A, ChS-E, heparin, and dextran sulfate inhibited invasion of adult worms into intestinal mucosa in vivo. No significant inhibition was observed with ChS-C, desulfated chondroitin, and dextran. ChS-E, heparin, and dextran sulfate inhibited adhesion of S. venezuelensis adult worms to plastic surfaces in vitro. Furthermore, binding of intestinal epithelial cells to adhesion substances of S. venezuelensis, which have been implicated in mucosal invasion, was inhibited by ChS-E, heparin, and dextran sulfate. Because adult worms of S. venezuelensis were actively moving in the intestinal mucosa, probably exiting and reentering during infection, the possible expulsion mechanism for S. venezuelensis is inhibition by mast cell glycosaminoglycans of attachment and subsequent invasion of adult worms into intestinal epithelium.
Maruyama
H
H
Department of Medical Zoology, Nagoya City University Medical School, Nagoya, Japan. maruyama@med.nagoya-cu.ac.jp
Yabu
Y
Y
Yoshida
A
A
Nawa
Y
Y
Ohta
N
N
D000818:Animals; D018938:Caco-2 Cells; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000276:immunology; D002809:Chondroitin Sulfates / Q000276:immunology; D004386:Duodenum / Q000276:immunology / Q000469:parasitology / Q000648:ultrastructure; D006025:Glycosaminoglycans / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000276:immunology* / Q000469:parasitology / Q000473:pathology / Q000517:prevention & control; D007413:Intestinal Mucosa / Q000276:immunology / Q000469:parasitology / Q000648:ultrastructure; D008297:Male; D008407:Mast Cells / Q000276:immunology* / Q000378:metabolism; D008415:Mastocytosis / Q000276:immunology / Q000469:parasitology / Q000473:pathology / Q000517:prevention & control; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D051381:Rats; D017208:Rats, Wistar; D013321:Strongyloides / Q000276:immunology* / Q000472:pathogenicity / Q000648:ultrastructure; D013322:Strongyloidiasis / Q000276:immunology* / Q000469:parasitology / Q000517:prevention & control
D002241:Carbohydrates; D006025:Glycosaminoglycans; D002809:Chondroitin Sulfates